Table 1.
Demographic characteristics and pre-existing co-morbidities 1.
| CoronaVac Group (n = 98) | BNT162b2 Group (n = 136) |
p-Value 2 (<65) |
p-Value 2 (≥65) |
|||
|---|---|---|---|---|---|---|
| Age < 65 (n = 78) |
Age ≥ 65 (n = 20) |
Age < 65 (n = 93) |
Age ≥ 65 (n = 43) |
|||
| Female | 42 (53.8%) | 5 (25%) | 53 (57.0%) | 12 (27.9%) | 0.76 | >0.99 |
| Mean age | 49.9 (S.D.9.0) | 70.4 (S.D.3.4) | 52.0 (S.D.7.8) | 70.9 (S.D.5.6) | 0.10 | 0.65 |
| Cardiovascular diseases | 1 (1.3%) | 6 (30.0%) | 1 (1.1%) | 6 (14.0%) | >0.99 | 0.17 |
| Stroke | 0 | 0 | 1 (1.1%) | 0 | >0.99 | >0.99 |
| Hypertension | 16 (20.5%) | 10 (50.0%) | 19 (20.4%) | 20 (46.5%) | >0.99 | >0.99 |
| Diabetes mellitus | 4 (5.1%) | 8 (40.0%) | 6 (6.5%) | 5 (11.6%) | 0.76 | 0.017 |
| Hyperlipidemia | 14 (17.9%) | 6 (30.0%) | 12 (12.9%) | 12 (27.9%) | 0.40 | >0.99 |
| Asthma | 2 (2.6%) | 0 | 0 | 2 (4.7%) | 0.21 | >0.99 |
| Chronic renal diseases | 0 | 0 | 1 (1.1%) | 0 | >0.99 | >0.99 |
| Chronic liver diseases | 2 (2.6%) | 0 | 1 (1.1%) | 0 | 0.59 | >0.99 |
| Cancer | 1 (1.3%) | 0 | 7 (7.5%) | 7 (16.3%) | 0.07 | >0.99 |
| Received chemotherapy and/or radiotherapy | 0 | 0 | 0 | 0 | >0.99 | >0.99 |
| Steroid 3 | 0 | 1 (5.0%) | 3 (3.2%) | 2 (4.7%) | 0.25 | >0.99 |
| AIDS 4 | 0 | 0 | 0 | 0 | >0.99 | >0.99 |
| Systemic lupus erythematosus | 0 | 0 | 1 (1.1%) | 0 | >0.99 | >0.99 |
| Other autoimmune diseases | 1 (1.3%) | 0 | 6 (6.5%) | 2 (4.7%) | 0.12 | >0.99 |
| Food/drug allergy | 0 | 0 | 0 | 0 | >0.99 | >0.99 |
1 Individual may have more than one co-morbidity. 2 p < 0.05, the results are significantly different. 3 Steroid dosage of ≥7.5 mg per day prednisolone equivalents. 4 AIDS: Acquired Immunodeficiency (Virus) Syndrome. Mean age was tested using two sample t-test. Other variables were tested using Fisher’s exact test.